Market Overview:
The global esomeprazole market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of gastrointestinal diseases, increasing awareness about gastroesophageal reflux disease (GERD) and its treatment options, and growing demand for over-the-counter (OTC) drugs. However, patent expirations of key esomeprazole products is expected to restrain the growth of the market during the forecast period. Based on type, the global esomeprazole market can be segmented into capsule, tablet, and others. Capsule accounted for a major share of the global esomeprazole market in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to their ease of use and high patient compliance rates as compared with tablets or other forms of esomeprazole products. Tablet form is expected to grow at a higher CAGR than capsule form during 2018–2030 owing to their lower prices as compared with capsules and growing preference for tablet formulations by patients due To this factor,. On basis if application ,Gastroesophageal Reflux Disease (GERD) accounted for majority share in 2017and it will continue dominate throughout Forecast Period .
Product Definition:
Esomeprazole is a proton pump inhibitor used to treat gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome. Esomeprazole decreases the amount of acid produced in the stomach.
Capsule:
Capsule is a small container that holds the medicine. It is used to administer medicines in patients and it can be oral or non-oral depending on the type of drug. The capsule has two parts, an outer shell and an inner core which contains the medicine. There are different types of capsules such as film, soft gel, liquid filled etc., depending upon what kind of drug it contains.
Capsules have many advantages over other forms such as they are easy to swallow for patients.
Tablet:
A tablet is a pharmaceutical dosage unit consisting of an amount of drug substance mixed with filler to make it disintegrate or dissolve properly. The drug substances can be any kind of drugs like tablets for children contain usually less than the adult dose. Tablets are available in different sizes and shapes which helps in easy identification and selection by the patients.
Esomeprazole is used for treatment against heartburn, indigestion, reflux esophagitis,.
Application Insights:
Gastroesophageal reflux disease (GERD) was the largest application segment in 2017. The product is used for the treatment of acid regurgitation and heartburn. Acid reflux occurs when food debris, stomach acids or pepsin reach the lower esophagus, a condition known to affect nearly 40-50% of adults. Esomeprazole is also used for treating duodenal ulcers and other conditions related to Zollinger-Ellison syndrome. Others include Crohn¢â‚¬â„¢s disease, gastritis and gastroenteritis among others.
Regional Analysis:
Europe dominated the global esomeprazole market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the high prevalence of acid reflux disease and Duodenal Ulcer Disease (DU) in this region as compared to other regions, which has led to an increase in demand for proton pump inhibitors such as esomeprazole. Moreover, factors such as technological advancements and rising awareness about lifestyle changes are expected to drive the regional market during the forecast period.
Growth Factors:
- Increasing prevalence of gastrointestinal diseases: The increasing prevalence of gastrointestinal diseases is one of the key growth drivers for the Esomeprazole market. Esomeprazole is used to treat various gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome. The rising incidence of these diseases is expected to drive the demand for Esomeprazole in the coming years.
- Growing awareness about GERD: There is a growing awareness among people about GERD and its treatment options, which is driving the demand for Esomeprazole products worldwide.
- Rising number of product approvals: The number of product approvals for Esomeprazole has been increasing in recent years, owing to its efficacy in treating various gastrointestinal disorders. This is likely to boost the growth prospects of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Esomeprazole Market Research Report
By Type
Capsule, Tablet, Others
By Application
Gastroesophageal Reflux Disease, Duodenal Ulcers, Others
By Companies
AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi, Mepha, Saval Pharmaceutical, AstraZeneca AB, Blaskov, CQ Lummy
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Esomeprazole Market Report Segments:
The global Esomeprazole market is segmented on the basis of:
Types
Capsule, Tablet, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gastroesophageal Reflux Disease, Duodenal Ulcers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca AB
- Sandoz
- Actavis
- Teva.
- Mylan
- KernPharm
- Garmish Pharmaceuticals
- Sanofi
- Mepha
- Saval Pharmaceutical
- AstraZeneca AB
- Blaskov
- CQ Lummy
Highlights of The Esomeprazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Tablet
- Others
- By Application:
- Gastroesophageal Reflux Disease
- Duodenal Ulcers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Esomeprazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Esomeprazole is a proton pump inhibitor (PPI) that is used to treat gastroesophageal reflux disease (GERD). Esomeprazole works by reducing the amount of acid that flows from the stomach into the esophagus. This can help relieve symptoms such as heartburn, regurgitation, and difficulty swallowing. Esomeprazole is also used to prevent GERD episodes in people who are at risk for them.
Some of the major players in the esomeprazole market are AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi, Mepha, Saval Pharmaceutical, AstraZeneca AB, Blaskov, CQ Lummy.
The esomeprazole market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Esomeprazole Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Esomeprazole Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Esomeprazole Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Esomeprazole Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Esomeprazole Market Size & Forecast, 2020-2028
4.5.1 Esomeprazole Market Size and Y-o-Y Growth
4.5.2 Esomeprazole Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsule
5.2.2 Tablet
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Gastroesophageal Reflux Disease
6.2.2 Duodenal Ulcers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Esomeprazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Esomeprazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsule
9.6.2 Tablet
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Gastroesophageal Reflux Disease
9.10.2 Duodenal Ulcers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsule
10.6.2 Tablet
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Gastroesophageal Reflux Disease
10.10.2 Duodenal Ulcers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsule
11.6.2 Tablet
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Gastroesophageal Reflux Disease
11.10.2 Duodenal Ulcers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsule
12.6.2 Tablet
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Gastroesophageal Reflux Disease
12.10.2 Duodenal Ulcers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsule
13.6.2 Tablet
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Gastroesophageal Reflux Disease
13.10.2 Duodenal Ulcers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Esomeprazole Market: Competitive Dashboard
14.2 Global Esomeprazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca AB
14.3.2 Sandoz
14.3.3 Actavis
14.3.4 Teva.
14.3.5 Mylan
14.3.6 KernPharm
14.3.7 Garmish Pharmaceuticals
14.3.8 Sanofi
14.3.9 Mepha
14.3.10 Saval Pharmaceutical
14.3.11 AstraZeneca AB
14.3.12 Blaskov
14.3.13 CQ Lummy
